Previous study by Asghar U indicated that a subset of triple-negative breast cancer cells with expression of AR and the loss of cyclin E1 could be responsive to CDK4/6 inhibition [86]. This evidence concerns the gene CCNE1 and triple-negative breast carcinoma.